共 50 条
- [35] Clinicopathological characteristics of kidney injury in non-small cell lung cancer patients under combination therapy including pembrolizumab CEN Case Reports, 2022, 11 : 97 - 104
- [37] First-line Therapy for advanced clear cell Renal Cell Carcinoma An open-label, randomized, Phase III Study for Evaluating the Efficacy and Safety of Pembrolizumab (MK-3475) in combination with Belzutifan (MK-6482) and Lenvatinib (MK-7902) or MK-1308A in combination with Lenvatinib versus Pembrolizumab and Lenvatinib as First-line Treatment in Participants with advanced Clear Cell Renal Cell Carcinoma (ccRCC) (AUO AN 54/21, HIF-012) AKTUELLE UROLOGIE, 2022, 53 (05) : 400 - 401
- [40] Non-Invasive Prevention of Malignant Airway Obstruction in an Elderly Lung Cancer Patient Using Early Chemo Combination With Pembrolizumab Therapy: A Case Study RESPIROLOGY CASE REPORTS, 2025, 13 (03):